Abstract 332: Toward Big Data: Integrating Cardiovascular Registry and Claims Data to Create a Clinical Practice-based Analytical Platform

Author(s):  
Gregory P Hess ◽  
Eileen Fonseca ◽  
James Beachy ◽  
Frederick A Masoudi ◽  
John S Rumsfeld

Background: There is great promise in ‘big data’ analytics that leverage multiple data sources including clinical registries and claims data, creating large, broadly distributed, and clinically detailed analytical platforms to study a range of cardiovascular topics, including practice patterns associated with optimal clinical outcomes. Objective: Describe a newly created integrated analytical platform utilizing U.S. cardiovascular registry records and healthcare claims data from real-world clinical practices. Methods: The analytical platform includes records from five American College of Cardiology (ACC) National Cardiovascular Data Registry programs and pharmacy, private practitioner and hospital claims data from Symphony Health Solutions (SHS). The NCDR registries include ≈ 650,000 patients in ACTION Registry-GWTG (acute coronary syndrome), 6.7m in CathPCI (diagnostic cardiac catheterizations and PCI), 660,000 in ICD (implantable cardioverter defibrillators), 33,000 in IMPACT (pediatric and adult congenital treatment) and 3.4m in PINNACLE (ambulatory CAD, HTN, HF and AFib). With history as early as 2003, SHS currently receives one or more pharmacy, practitioner or hospital claims annually for ≈274m patients in the U.S. All payer types are represented, including self-pay pharmacy patients. Patient inclusion criteria: 1) Data within 2006 [[Unable to Display Character: –]] 2014, 2) one or more records in ≥ 1 of 5 NCDR registries, 3) one or more claims observed in ≥ 1 of 3 SHS datasets: pharmacy, private practitioner or hospital claims, 4) populated data fields enabling generation of a unique, patient-level, synthetic identifier (ID) for matching and longitudinal linkage across the registry(s) and the dataset(s). The analytical platform has been developed using a HIPAA and HITECH compliant, certified approach. Results: Over 8.7 million patients have been successfully linked between the NCDR registries and the SHS claims data. On average, 95% of patients in the registry(s) sample was also observed and matched in the SHS datasets. Conclusion: High match rates were observed between the ACC and SHS data, identifying large populations of patients with cardiovascular disease. Clinical registry data combined with longitudinal claims data will generate a ‘broad’ and ‘deep’ data platform for analytics of quality of care and outcomes.

Author(s):  
Sushruta Mishra ◽  
Hrudaya Kumar Tripathy ◽  
Brojo Kishore Mishra ◽  
Soumya Sahoo

Big data analytics is a growth area with the potential to provide useful insight in healthcare. Big Data can unify all patient related data to get a 360-degree view of the patient to analyze and predict outcomes. It can improve clinical practices, new drug development and health care financing process. It offers a lot of benefits such as early disease detection, fraud detection and better healthcare quality and efficiency. This chapter introduces the Big Data concept and characteristics, health care data and some major issues of Big Data. These issues include Big Data benefits, its applications and opportunities in medical areas and health care. Methods and technology progress about Big Data are presented in this study. Big Data challenges in medical applications and health care are also discussed. While many dimensions of big data still present issues in its use and adoption, such as managing the volume, variety, velocity, veracity, and value, the accuracy, integrity, and semantic interpretation are of greater concern in clinical application.


Author(s):  
Nadine E Andrew ◽  
Dominique A Cadilhac ◽  
Vijaya Sundararajan ◽  
Amanda G Thrift ◽  
Phil Anderson ◽  
...  

IntroductionRecent advances in Australia mean that it is possible to link national clinical registries with government held administrative datasets. However, formal evaluations of such activities and the potential impact for research are lacking. Objectives and ApproachWe aimed to assess the feasibility and accuracy of linking registrants from the Australian Stroke Clinical Registry (AuSCR) with the Medicare enrolment file. Following data custodian and ethics approvals, personal linkage identifiers were submitted to the Australian Institute of Health and Welfare (AIHW). De-identified data from AuSCR and the AIHW were submitted into the Secure Unified Research Environment and merged using project specific person-based IDs. We calculated the proportion of patients linked with the Medicare enrolment file that were present in the associated Medicare and medication dispensing datasets and the proportion with claims after their date of death. Logistic regression was used to identify factors associated with a non-merged patient. Results17,980 AuSCR registrants (January 2010-July 2014) were submitted for linkage (median age 76 years; 46% female; 67% ischaemic stroke; 16% TIA). Of these, 93% were merged with Medicare (N=16,648) and 95% with subsidised medication dispensing claims data (N=17,079). In those who died, 127 (0.8%) had one or more Medicare claim and 411 (2.4%) had one or more medications dispensed after their death date. Asian born registrants were less likely to be merged with Medicare (adjusted Odds Ratio [aOR]: 0.54; 95% Confidence Interval [CI]: 0.40, 0.72) than Australian born registrants. Those aged ≥85 years were less likely to be merged with Medicare data than those aged <65 years (aOR 0.24; 95% CI: 0.19, 0.29) but were more likely to be merged with dispensing data (aOR: 2.22 (95% CI: 1.73, 2.84). Conclusion/ImplicationsLinkage between a national clinical quality registry and the Medicare spine is feasible. These linkages will provide novel insights into post-stroke care.


2022 ◽  
pp. 417-430
Author(s):  
Sushruta Mishra ◽  
Hrudaya Kumar Tripathy ◽  
Brojo Kishore Mishra ◽  
Soumya Sahoo

Big data analytics is a growth area with the potential to provide useful insight in healthcare. Big Data can unify all patient related data to get a 360-degree view of the patient to analyze and predict outcomes. It can improve clinical practices, new drug development and health care financing process. It offers a lot of benefits such as early disease detection, fraud detection and better healthcare quality and efficiency. This chapter introduces the Big Data concept and characteristics, health care data and some major issues of Big Data. These issues include Big Data benefits, its applications and opportunities in medical areas and health care. Methods and technology progress about Big Data are presented in this study. Big Data challenges in medical applications and health care are also discussed. While many dimensions of big data still present issues in its use and adoption, such as managing the volume, variety, velocity, veracity, and value, the accuracy, integrity, and semantic interpretation are of greater concern in clinical application.


2021 ◽  
Vol 17 (12) ◽  
pp. 119-134
Author(s):  
Atif M. Gattan

The current examination is to break down the information dependent on the Big Data Analytics in enhancing electronic medical records in clinics and wellbeing focuses. Numerous emergency clinics and medical services habitats are experiencing incapable utilization of enormous information investigation in streamlining electronic medical records (EMRs) to create great bits of knowledge for their clinical practices. Hierarchical conduct and the exercises associated with the medical field are the principal factors in improving the utilization of Big Data Analytics in EMRs. The examination centres around exploring the how the models and methods of information can accomplish enormous information life cycle in EMRs. The examination likewise uncovers the information put together investigation with respect to EMRs use and capacity that assists with improving the significant usage of huge information rehearses. The investigation contributes on advanced wellbeing rehearses by investigating the appropriate adaption of scientific instruments to EMRs to shape the significant utilization of large information examination with EMRs.


Author(s):  
Manbir Sandhu ◽  
Purnima, Anuradha Saini

Big data is a fast-growing technology that has the scope to mine huge amount of data to be used in various analytic applications. With large amount of data streaming in from a myriad of sources: social media, online transactions and ubiquity of smart devices, Big Data is practically garnering attention across all stakeholders from academics, banking, government, heath care, manufacturing and retail. Big Data refers to an enormous amount of data generated from disparate sources along with data analytic techniques to examine this voluminous data for predictive trends and patterns, to exploit new growth opportunities, to gain insight, to make informed decisions and optimize processes. Data-driven decision making is the essence of business establishments. The explosive growth of data is steering the business units to tap the potential of Big Data to achieve fueling growth and to achieve a cutting edge over their competitors. The overwhelming generation of data brings with it, its share of concerns. This paper discusses the concept of Big Data, its characteristics, the tools and techniques deployed by organizations to harness the power of Big Data and the daunting issues that hinder the adoption of Business Intelligence in Big Data strategies in organizations.


2019 ◽  
Vol 54 (5) ◽  
pp. 20
Author(s):  
Dheeraj Kumar Pradhan

2020 ◽  
Vol 49 (5) ◽  
pp. 11-17
Author(s):  
Thomas Wrona ◽  
Pauline Reinecke

Big Data & Analytics (BDA) ist zu einer kaum hinterfragten Institution für Effizienz und Wettbewerbsvorteil von Unternehmen geworden. Zu viele prominente Beispiele, wie der Erfolg von Google oder Amazon, scheinen die Bedeutung zu bestätigen, die Daten und Algorithmen zur Erlangung von langfristigen Wettbewerbsvorteilen zukommt. Sowohl die Praxis als auch die Wissenschaft scheinen geradezu euphorisch auf den „Datenzug“ aufzuspringen. Wenn Risiken thematisiert werden, dann handelt es sich meist um ethische Fragen. Dabei wird häufig übersehen, dass die diskutierten Vorteile sich primär aus einer operativen Effizienzperspektive ergeben. Strategische Wirkungen werden allenfalls in Bezug auf Geschäftsmodellinnovationen diskutiert, deren tatsächlicher Innovationsgrad noch zu beurteilen ist. Im Folgenden soll gezeigt werden, dass durch BDA zwar Wettbewerbsvorteile erzeugt werden können, dass aber hiermit auch große strategische Risiken verbunden sind, die derzeit kaum beachtet werden.


2019 ◽  
Vol 7 (2) ◽  
pp. 273-277
Author(s):  
Ajay Kumar Bharti ◽  
Neha Verma ◽  
Deepak Kumar Verma

2017 ◽  
Vol 49 (004) ◽  
pp. 825--830
Author(s):  
A. AHMED ◽  
R.U. AMIN ◽  
M. R. ANJUM ◽  
I. ULLAH ◽  
I. S. BAJWA

Sign in / Sign up

Export Citation Format

Share Document